Breast cancer: further metabolic-endocrine risk markers? (Q36431629)

14 August 2017

1 reference

17 June 2019

Breast cancer: further metabolic-endocrine risk markers? (English)

1 reference

14 August 2017

1 reference

17 June 2019

Stoll BA

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

14 August 2017

4 references

14 August 2017

13 March 2019

3 April 2019

17 June 2019

76

1 reference

14 August 2017

12

1 reference

14 August 2017

1652-1654

1 reference

Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Insulin and glucose status, tissue and plasma lipids in patients with tumours of the ovary or endometrium: possible dietary implications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

30 September 2017

Insulin and colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

The insulin-like growth factor system as a target in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Banting lecture 1988. Role of insulin resistance in human disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

The physiological role of IGFBP-1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Effect of systemic hyperinsulinemia in cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Insulin resistance in patients with colorectal cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Insulin resistance and breast-cancer risk

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228209

Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level

28 June 2018

1 reference

12 December 2020

International comparisons concerning breast cancer and steroid receptors

1 reference

12 December 2020

The influence of obesity and age at diagnosis on the estrogen receptor status of breast cancers. Perimenopausal predominance of estrogen receptor negative tumors

1 reference

12 December 2020

Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer

1 reference

12 December 2020

Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors

1 reference

12 December 2020

Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases

1 reference

12 December 2020

Growth hormone increases rate of pubertal maturation

1 reference

12 December 2020

Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-I messenger ribonucleic acid of rat mammary gland

1 reference

12 December 2020

Estrogen and progesterone receptors in the normal female breast

1 reference

12 December 2020

Steroid receptors in breast cancer patients. Influence of obesity and age at diagnosis

1 reference

12 December 2020

Distribution of estrogen receptor in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer

1 reference

12 December 2020

Hyperinsulinemia as a factor modifying sensitivity of endometrial carcinoma to hormonal influences

1 reference

12 December 2020

Evidence that the growth hormone receptor mediates differentiation and development of the mammary gland

1 reference

12 December 2020

Estrogen receptor expression of benign breast epithelium and its association with breast cancer

1 reference

12 December 2020

Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues

1 reference

12 December 2020

The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients

1 reference

12 December 2020

Effects of tumor removal and body weight loss on insulin resistance in patients with cancer

1 reference

12 December 2020

The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

1 reference

12 December 2020

Role of insulin-like growth factors in steroid modulated proliferation

1 reference

12 December 2020

Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function

1 reference

12 December 2020

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer

1 reference

12 December 2020

IGF binding protein-3 protease regulation: how sweet it is!

1 reference

12 December 2020

Expression of the gene encoding growth hormone in the human mammary gland

1 reference

12 December 2020

Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status

1 reference

12 December 2020

Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate

1 reference

12 December 2020

Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.612

1 reference

release_2tv7ukbuxvgttnshx3jexcopty

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2tv7ukbuxvgttnshx3jexcopty

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

PubMed publication ID

9413957

1 reference